Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and s 1033

3,4-dihydroxyphenylacetic acid has been researched along with s 1033 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, J; Arellano, J; Fowler, AJ; Hebron, ML; Howard, HH; Lawler, A; Liu, X; Matar, S; Moussa, C; Mundel, EE; Pagan, FL; Peyton, M; Schwartz, SL; Starr, NJ; Torres-Yaghi, Y; Wilmarth, B; Yusuf, N	1

Trials

1 trial(s) available for 3,4-dihydroxyphenylacetic acid and s 1033

Article	Year
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease. Pharmacology research & perspectives, 2019, Volume: 7, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; alpha-Synuclein; Biomarkers; Brain; Cohort Studies; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Drugs, Investigational; Homovanillic Acid; Humans; Membrane Glycoproteins; Middle Aged; Parkinson Disease; Placebos; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptors, Immunologic	2019

Article

Year

Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.

Pharmacology research & perspectives, 2019, Volume: 7, Issue:2

Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; alpha-Synuclein; Biomarkers; Brain; Cohort Studies; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Drugs, Investigational; Homovanillic Acid; Humans; Membrane Glycoproteins; Middle Aged; Parkinson Disease; Placebos; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptors, Immunologic

2019